Drug Companies Planning to Dump Experimental and Controversial Vaccines in Public Schools

Drug companies, along with the Department of Health and Human Services and the Centers for Disease Control, have allocated millions of dollars in funding to establish vaccine clinics in public schools.

One grant, given to Denver Public Schools, provides cash for vaccinating children with the newly approved diphtheria toxoid and acellular pertussis vaccine (Tdap), meningococcal conjugate vaccine (MCV4), and human papillomavirus vaccine (HPV). The lead investigator of Denver In-School Immunization Project, Dr. Judith Shlay, says that if all goes well, plans are in place to implement school-base vaccine clinics across the U.S.

According to Prevent Disease:

“Put into context, the implications of the Denver In-School Immunization Project are enormous. We are speaking of a captured market for vaccine manufacturers (guaranteed purchase of vaccines), insurance companies (guaranteed rise in premiums), and government funding (VFC) all footed by taxpayer dollars. The total price per vaccinated adolescent in the private sector is approximately $500”.

+ Sources and References
Post your comment